US Patent 8105612 Serum resistance factors of gram positive bacteria
Patent 8105612 was granted and assigned to Novartis on January, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8105612 Serum resistance factors of gram positive bacteria
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
